review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1041359599 |
P356 | DOI | 10.1186/1559-0275-11-8 |
P932 | PMC publication ID | 4015695 |
P698 | PubMed publication ID | 24593906 |
P5875 | ResearchGate publication ID | 260523833 |
P2093 | author name string | Gerald W Hart | |
Junfeng Ma | |||
P2860 | cites work | Phosphofructokinase 1 glycosylation regulates cell growth and metabolism | Q24297510 |
Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry | Q24561920 | ||
Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain | Q24561943 | ||
The utility of ETD mass spectrometry in proteomic analysis | Q24682151 | ||
Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry | Q27334695 | ||
Structure-based design of beta 1,4-galactosyltransferase I (beta 4Gal-T1) with equally efficient N-acetylgalactosaminyltransferase activity: point mutation broadens beta 4Gal-T1 donor specificity | Q27638603 | ||
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics | Q28131742 | ||
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags | Q28145324 | ||
Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry | Q28204943 | ||
Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications | Q28215287 | ||
Proteomics by mass spectrometry: approaches, advances, and applications | Q28243072 | ||
Localization of O-GlcNAc modification on the serum response transcription factor | Q28259727 | ||
Quantitative proteomics using stable isotope labeling with amino acids in cell culture | Q28271745 | ||
Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons | Q28293769 | ||
A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC) | Q28296386 | ||
Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins | Q28299550 | ||
Cytologic assessment of nuclear and cytoplasmic O-linked N-acetylglucosamine distribution by using anti-streptococcal monoclonal antibodies | Q28329475 | ||
Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose | Q28573520 | ||
Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse | Q28594444 | ||
Super-SILAC mix for quantitative proteomics of human tumor tissue | Q39719028 | ||
O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells | Q39969650 | ||
Identification of new O-GlcNAc modified proteins using a click-chemistry-based tagging | Q39998103 | ||
Proteomic analysis of O-GlcNAc modifications derived from streptozotocin and glucosamine induced beta-cell apoptosis | Q40042717 | ||
Tagging-via-substrate strategy for probing O-GlcNAc modified proteins. | Q40410441 | ||
Stable-isotope dimethyl labeling for quantitative proteomics | Q40608471 | ||
Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance | Q41179543 | ||
Direct in-gel fluorescence detection and cellular imaging of O-GlcNAc-modified proteins | Q42040937 | ||
Detection and analysis of proteins modified by O-linked N-acetylglucosamine | Q42157350 | ||
O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry | Q42679419 | ||
Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine | Q43634630 | ||
Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody | Q43713127 | ||
Identification of GlcNAcylation sites of peptides and alpha-crystallin using Q-TOF mass spectrometry | Q43769874 | ||
Identification of substituted sites on MUC5AC mucin motif peptides after enzymatic O-glycosylation combining beta-elimination and fixed-charge derivatization | Q43831385 | ||
Identification of Ewing's sarcoma gene product as a glycoprotein using a monoclonal antibody that recognizes an immunodeterminant containing O-linked N-acetylglucosamine moiety | Q44112687 | ||
Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene | Q44264485 | ||
Identification of novel sites of O-N-acetylglucosamine modification of serum response factor using quadrupole time-of-flight mass spectrometry. | Q44396316 | ||
A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications | Q44704206 | ||
O-GlcNAcPRED: a sensitive predictor to capture protein O-GlcNAcylation sites | Q44776406 | ||
Quantitative analysis of both protein expression and serine / threonine post-translational modifications through stable isotope labeling with dithiothreitol | Q45222216 | ||
Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer. | Q45951647 | ||
Mapping of O-linked beta-N-acetylglucosamine modification sites in key contractile proteins of rat skeletal muscle. | Q46074241 | ||
Multiple reaction monitoring mass spectrometry for the discovery and quantification of O-GlcNAc-modified proteins | Q46186432 | ||
SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function | Q46458771 | ||
Identification of structural and functional O-linked N-acetylglucosamine-bearing proteins in Xenopus laevis oocyte | Q46490483 | ||
Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase | Q46669689 | ||
Posttranslational modifications on protein kinase c isozymes. Effects of epinephrine and phorbol esters | Q46737360 | ||
Global identification of O-GlcNAc-modified proteins | Q46891762 | ||
Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. | Q51758332 | ||
Glycosylation of chromosomal proteins: localization of O-linked N-acetylglucosamine in Drosophila chromatin. | Q52452782 | ||
The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. | Q54426511 | ||
Purification and Identification ofO-GlcNAc-Modified Peptides Using Phosphate-Based Alkyne CLICK Chemistry in Combination with Titanium Dioxide Chromatography and Mass Spectrometry | Q57279142 | ||
Simultaneous Detection and Identification of O-GlcNAc-Modified Glycoproteins Using Liquid Chromatography−Tandem Mass Spectrometry | Q58055863 | ||
Selective Detection and Site-Analysis of O-GlcNAc-Modified Glycopeptides by β-Elimination and Tandem Electrospray Mass Spectrometry | Q63361145 | ||
High-sensitivity FAB-MS strategies for O-GlcNAc characterization | Q67895365 | ||
Determination and location of phosphoserine in proteins and peptides by conversion to S-ethylcysteine | Q68047824 | ||
Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc | Q70466786 | ||
RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc | Q70695837 | ||
Specific isolation of O-linked N-acetylglucosamine glycopeptides from complex mixtures | Q70927036 | ||
Identification of O-GlcNAc sites on proteins | Q79372176 | ||
Discovery of O-GlcNAc-modified proteins in published large-scale proteome data | Q28714168 | ||
Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents | Q29547450 | ||
Electrospray ionization for mass spectrometry of large biomolecules | Q29618001 | ||
O-Linked β-N-acetylglucosamine (O-GlcNAc) regulates emerin binding to barrier to autointegration factor (BAF) in a chromatin- and lamin B-enriched "niche". | Q30410148 | ||
Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets | Q30424053 | ||
O-GlcNAcylation of the Plum pox virus capsid protein catalyzed by SECRET AGENT: characterization of O-GlcNAc sites by electron transfer dissociation mass spectrometry | Q30431005 | ||
Enrichment and site mapping of O-linked N-acetylglucosamine by a combination of chemical/enzymatic tagging, photochemical cleavage, and electron transfer dissociation mass spectrometry | Q30433713 | ||
Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis | Q30436151 | ||
Regulation of calcium/calmodulin-dependent kinase IV by O-GlcNAc modification. | Q30490721 | ||
Metabolic cross-talk allows labeling of O-linked beta-N-acetylglucosamine-modified proteins via the N-acetylgalactosamine salvage pathway | Q30498243 | ||
Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation | Q33284870 | ||
O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress | Q33625265 | ||
O-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs | Q33628891 | ||
Activation of the transcriptional function of the NF-κB protein c-Rel by O-GlcNAc glycosylation | Q33791683 | ||
Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc | Q33802435 | ||
Enrichment of O-GlcNAc modified proteins by the periodate oxidation-hydrazide resin capture approach | Q33835452 | ||
Chemoselective attachment of small molecule effector functionality to human adenoviruses facilitates gene delivery to cancer cells. | Q33862005 | ||
dbOGAP - an integrated bioinformatics resource for protein O-GlcNAcylation. | Q33863321 | ||
A novel two-stage tandem mass spectrometry approach and scoring scheme for the identification of O-GlcNAc modified peptides | Q33864754 | ||
O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation | Q33883510 | ||
Quantitative, high-resolution proteomics for data-driven systems biology | Q33891413 | ||
O-GlcNAc cycling enzymes associate with the translational machinery and modify core ribosomal proteins | Q33907013 | ||
Identification of glycosylation sites in mucin peptides by edman degradation | Q33924275 | ||
Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags | Q34075637 | ||
Prediction of glycosylation across the human proteome and the correlation to protein function. | Q34121596 | ||
Mapping of O-GlcNAc sites of 20 S proteasome subunits and Hsp90 by a novel biotin-cystamine tag. | Q34255802 | ||
Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. | Q34330440 | ||
Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code | Q34359019 | ||
Characterization of O-GlcNAc cycling and proteomic identification of differentially O-GlcNAcylated proteins during G1/S transition | Q34411458 | ||
Glycomics Hits the Big Time | Q34432774 | ||
Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics | Q34627638 | ||
Higher-energy C-trap dissociation for peptide modification analysis. | Q34667664 | ||
Protein microarrays: high-throughput tools for proteomics | Q34977186 | ||
Chemical reporters for fluorescent detection and identification of O-GlcNAc-modified proteins reveal glycosylation of the ubiquitin ligase NEDD4-1 | Q35002612 | ||
Two-dimensional gel electrophoresis in proteomics: Past, present and future | Q37777786 | ||
O-GlcNAc modification, insulin signaling and diabetic complications. | Q37809205 | ||
Proteomic databases and tools to decipher post-translational modifications | Q37943686 | ||
Mass spectrometry-based proteomics and network biology | Q37996108 | ||
O-GlcNAc cycling: a link between metabolism and chronic disease | Q38103951 | ||
O-GlcNAc in cancer biology | Q38120210 | ||
Protein O-GlcNAcylation in diabetes and diabetic complications | Q38132916 | ||
Comparative analysis by frontal affinity chromatography of oligosaccharide specificity of GlcNAc-binding lectins, Griffonia simplicifolia lectin-II (GSL-II) and Boletopsis leucomelas lectin (BLL). | Q38311586 | ||
Crystal structure of a wheat germ agglutinin/glycophorin-sialoglycopeptide receptor complex. Structural basis for cooperative lectin-cell binding | Q38327567 | ||
Bioaffinity chromatography in the 10 mM range of Kd. | Q38341845 | ||
Combining high-energy C-trap dissociation and electron transfer dissociation for protein O-GlcNAc modification site assignment | Q38403960 | ||
Polycomb repressive complex 2 is necessary for the normal site-specific O-GlcNAc distribution in mouse embryonic stem cells | Q35035129 | ||
A chemical approach for identifying O-GlcNAc-modified proteins in cells | Q35242785 | ||
Regulation of CK2 by phosphorylation and O-GlcNAcylation revealed by semisynthesis | Q35783386 | ||
Dynamic O-GlcNAc modification regulates CREB-mediated gene expression and memory formation | Q35784568 | ||
O-GlcNAc signalling: implications for cancer cell biology | Q35793071 | ||
Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease | Q35804446 | ||
The dynamic stress-induced “O-GlcNAc-ome” highlights functions for O-GlcNAc in regulating DNA damage/repair and other cellular pathways | Q35898104 | ||
Lectin-based structural glycomics: glycoproteomics and glycan profiling | Q35910289 | ||
O-GlcNAcylation of kinases | Q36070732 | ||
Peptide identification by tandem mass spectrometry with alternate fragmentation modes | Q36211835 | ||
Monoclonal antibodies identify a group of nuclear pore complex glycoproteins | Q36216116 | ||
Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine | Q36216148 | ||
O-GlcNAc cycling modulates neurodegeneration | Q36378423 | ||
Identification of O-linked N-acetylglucosamine (O-GlcNAc)-modified osteoblast proteins by electron transfer dissociation tandem mass spectrometry reveals proteins critical for bone formation | Q36742428 | ||
Selected reaction monitoring for quantitative proteomics: a tutorial | Q36973024 | ||
O-linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function | Q37040657 | ||
Site-specific GlcNAcylation of human erythrocyte proteins: potential biomarker(s) for diabetes | Q37066864 | ||
O-GlcNAcylation: A New Cancer Hallmark? | Q37086952 | ||
Dynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis. | Q37099485 | ||
Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification | Q37117710 | ||
Cracking the O-GlcNAc code in metabolism. | Q37197417 | ||
Identification of protein O-GlcNAcylation sites using electron transfer dissociation mass spectrometry on native peptides | Q37211310 | ||
Chemical derivatization of peptide carboxyl groups for highly efficient electron transfer dissociation | Q37308269 | ||
O-GlcNAc cycling: implications for neurodegenerative disorders | Q37376816 | ||
SPINDLY, a tetratricopeptide repeat protein involved in gibberellin signal transduction in Arabidopsis | Q37393011 | ||
Detecting the "O-GlcNAc-ome"; detection, purification, and analysis of O-GlcNAc modified proteins | Q37412378 | ||
Mass spectrometry-based label-free quantitative proteomics | Q37416474 | ||
18O2-labeling in quantitative proteomic strategies: a status report | Q37429056 | ||
O-GlcNAcomics--Revealing roles of O-GlcNAcylation in disease mechanisms and development of potential diagnostics | Q37445785 | ||
Two-dimensional gel-based approaches for the assessment of N-Linked and O-GlcNAc glycosylation in human and simian immunodeficiency viruses | Q37447351 | ||
The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways | Q37479201 | ||
Electron transfer dissociation (ETD): the mass spectrometric breakthrough essential for O-GlcNAc protein site assignments-a study of the O-GlcNAcylated protein host cell factor C1 | Q37705337 | ||
Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation | Q37736782 | ||
P433 | issue | 1 | |
P304 | page(s) | 8 | |
P577 | publication date | 2014-03-05 | |
P1433 | published in | Clinical Proteomics | Q5133793 |
P1476 | title | O-GlcNAc profiling: from proteins to proteomes | |
P478 | volume | 11 |
Q47634187 | A Chemoenzymatic Histology Method for O-GlcNAc Detection |
Q59127644 | A Novel Glycoproteomics Workflow Reveals Dynamic O-GlcNAcylation of COPγ1 as a Candidate Regulator of Protein Trafficking |
Q99557041 | A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry-based Glycoproteomics |
Q28080440 | A critical perspective of the diverse roles of O-GlcNAc transferase in chromatin |
Q35261648 | A little sugar goes a long way: the cell biology of O-GlcNAc |
Q38730380 | A mutant O-GlcNAcase enriches Drosophila developmental regulators. |
Q41492082 | A study of the structural properties of sites modified by the O-linked 6-N-acetylglucosamine transferase. |
Q34488445 | Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer |
Q50043076 | Analysis of Protein O-GlcNAcylation by Mass Spectrometry |
Q39418519 | Ancillary Activity: Beyond Core Metabolism in Immune Cells |
Q58735681 | Apart From Rhoptries, Identification of -GlcNAcylated Proteins Reinforces the Universality of the -GlcNAcome |
Q61809066 | Binding Specificity of Native Odorant-Binding Protein Isoforms Is Driven by Phosphorylation and -N-Acetylglucosaminylation in the Pig |
Q92995104 | Blocked O-GlcNAc cycling disrupts mouse hematopoeitic stem cell maintenance and early T cell development |
Q48192252 | Carb cutting works better with a partner |
Q64951629 | Caveolin-1 promotes invasion and metastasis by upregulating Pofut1 expression in mouse hepatocellular carcinoma. |
Q64095610 | Cell Metabolism Control Through O-GlcNAcylation of STAT5: A Full or Empty Fuel Tank Makes a Big Difference for Cancer Cell Growth and Survival |
Q92619790 | Characterization of Cell Glycocalyx with Mass Spectrometry Methods |
Q36998516 | Comprehensive mapping of O-GlcNAc modification sites using a chemically cleavable tag |
Q35172669 | Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis |
Q47218525 | Conditions Inducing Excessive O-GlcNAcylation Inhibit BMP2-Induced Osteogenic Differentiation of C2C12 Cells. |
Q34007175 | Deciphering the glycogenome of schistosomes |
Q38272067 | Detection and identification of O-GlcNAcylated proteins by proteomic approaches. |
Q58553621 | Direct Crosstalk Between -GlcNAcylation and Phosphorylation of Tau Protein Investigated by NMR Spectroscopy |
Q34562985 | Disruption of O-GlcNAc Cycling in C. elegans Perturbs Nucleotide Sugar Pools and Complex Glycans |
Q38932357 | Distinctive MS/MS Fragmentation Pathways of Glycopeptide-Generated Oxonium Ions Provide Evidence of the Glycan Structure. |
Q40065322 | Distributive O-GlcNAcylation on the Highly Repetitive C-Terminal Domain of RNA Polymerase II. |
Q58722448 | Effects of Acute Cold Stress on Liver -GlcNAcylation and Glycometabolism in Mice |
Q47617036 | Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase. |
Q37639440 | Eukaryotic protein glycosylation: a primer for histochemists and cell biologists |
Q37286799 | Exercise training increases protein O-GlcNAcylation in rat skeletal muscle |
Q42318355 | Extracellular Toxoplasma gondii tachyzoites metabolize and incorporate unnatural sugars into cellular proteins. |
Q36214824 | Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer |
Q38841301 | Global increase in O-linked N-acetylglucosamine modification promotes osteoblast differentiation |
Q42014372 | Glyco-seek: Ultrasensitive Detection of Protein-Specific Glycosylation by Proximity Ligation Polymerase Chain Reaction |
Q38569702 | Glycosylation in cancer: mechanisms and clinical implications |
Q26752363 | Hallmarks of glycosylation in cancer |
Q39032812 | Harnessing benefit from targeting tumor associated carbohydrate antigens |
Q47222188 | Higher O-GlcNAc Levels Are Associated with Defects in Progenitor Proliferation and Premature Neuronal Differentiation during in-Vitro Human Embryonic Cortical Neurogenesis. |
Q38430797 | Identification of methylated GnTI-dependent N-glycans in Botryococcus brauni |
Q37319145 | Identification of the nuclear localisation signal of O-GlcNAc transferase and its nuclear import regulation |
Q39285550 | In Vitro Biochemical Assays for O-GlcNAc-Processing Enzymes |
Q52340906 | Interactome analysis of transforming growth factor-β-activated kinase 1 in Helicobacter pylori-infected cells revealed novel regulators tripartite motif 28 and CDC37. |
Q59127958 | Involvement of O-GlcNAcylation in the Skeletal Muscle Physiology and Physiopathology: Focus on Muscle Metabolism |
Q88095064 | Mass Spectrometry Approaches to Glycomic and Glycoproteomic Analyses |
Q27001576 | Mass spectrometry-based detection and assignment of protein posttranslational modifications |
Q47227536 | Methods for the Detection, Study, and Dynamic Profiling of O-GlcNAc Glycosylation |
Q52714418 | MicroRNA-200a/200b Modulate High Glucose-Induced Endothelial Inflammation by Targeting O-linked N-Acetylglucosamine Transferase Expression. |
Q35871790 | Mixed Lineage Leukemia 5 (MLL5) Protein Stability Is Cooperatively Regulated by O-GlcNac Transferase (OGT) and Ubiquitin Specific Protease 7 (USP7). |
Q90616209 | Molecular Interrogation to Crack the Case of O-GlcNAc |
Q34683091 | Multiple tissue-specific roles for the O-GlcNAc post-translational modification in the induction of and complications arising from type II diabetes |
Q42964887 | Multiplexed Detection of O-GlcNAcome, Phosphoproteome, and Whole Proteome within the Same Gel. |
Q39098842 | New Opportunities and Challenges of Smart Polymers in Post-Translational Modification Proteomics. |
Q42318087 | O-GlcNAc Transferase Is Essential for Sensory Neuron Survival and Maintenance |
Q59125594 | O-GlcNAc as an Integrator of Signaling Pathways |
Q39241505 | O-GlcNAc cycling and the regulation of nucleocytoplasmic dynamics |
Q55416370 | O-GlcNAc cycling in the developing, adult and geriatric brain. |
Q33554587 | O-GlcNAc on NOTCH1 EGF repeats regulates ligand-induced Notch signaling and vascular development in mammals |
Q36096719 | O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity |
Q33810805 | O-GlcNAc-ylation in the Nuclear Pore Complex |
Q57174136 | O-GlcNAc: A Sweetheart of the Cell Cycle and DNA Damage Response |
Q64387509 | O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors |
Q92744216 | O-GlcNAcylation in immunity and inflammation: An intricate system (Review) |
Q92770698 | O-GlcNAcylation of ITGA5 facilitates the occurrence and development of colorectal cancer |
Q39028183 | O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies |
Q34426366 | O-GlcNAcylation, contractile protein modifications and calcium affinity in skeletal muscle |
Q49980779 | O-GlcNAcylation: key regulator of glycolytic pathways |
Q51185635 | O-Linked N-Acetylglucosamine (O-GlcNAc) Expression Levels Epigenetically Regulate Colon Cancer Tumorigenesis by Affecting the Cancer Stem Cell Compartment via Modulating Expression of Transcriptional Factor MYBL1. |
Q38846185 | Post-translational modifications in mitochondria: protein signaling in the powerhouse |
Q88487488 | Precision Profiling of the Cardiovascular Post-Translationally Modified Proteome: Where There Is a Will, There Is a Way |
Q41255028 | Predicting the Retention Behavior of Specific O-Linked Glycopeptides |
Q61448084 | Protein -GlcNAcylation in Cardiac Pathologies: Past, Present, Future |
Q92482072 | Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks |
Q38826163 | Protein-Specific Imaging of O-GlcNAcylation in Single Cells. |
Q38457777 | Proteomic analysis of O-GlcNAcylated proteins in invasive ductal breast carcinomas with and without lymph node metastasis |
Q41961186 | Proteomic analysis reveals O-GlcNAc modification on proteins with key regulatory functions in Arabidopsis. |
Q42798614 | Quantitative time-resolved chemoproteomics reveals that stable O-GlcNAc regulates box C/D snoRNP biogenesis |
Q42273521 | Recognition of diazirine-modified O-GlcNAc by human O-GlcNAcase |
Q51353442 | Recombinant fungal lectin as a new tool to investigate O-GlcNAcylation processes. |
Q38247344 | Role of O-GlcNAcylation in nutritional sensing, insulin resistance and in mediating the benefits of exercise |
Q48103560 | Structures of human O-GlcNAcase and its complexes reveal a new substrate recognition mode. |
Q64086779 | Sweet and Sour : Glycoproteomics and Phosphoproteomics Reveal New Players in Physiology and Pathogenesis |
Q28068399 | The Human Skeletal Muscle Proteome Project: a reappraisal of the current literature |
Q64260499 | The Role of Insulin Resistance and Protein O-GlcNAcylation in Neurodegeneration |
Q38719469 | The Sulfur-Linked Analogue of O-GlcNAc (S-GlcNAc) Is an Enzymatically Stable and Reasonable Structural Surrogate for O-GlcNAc at the Peptide and Protein Levels |
Q38533861 | The Utilities of Chemical Reactions and Molecular Tools for O-GlcNAc Proteomic Studies |
Q59906659 | Too sweet to resist: Control of immune cell function by O-GlcNAcylation |
Q33793649 | Tools for Studying Glycans: Recent Advances in Chemoenzymatic Glycan Labeling |
Q36104623 | Unsticking the Broken Diabetic Heart: O-GlcNAcylation and Calcium Sensitivity |
Q40960304 | WGA-based lectin affinity gel electrophoresis: A novel method for the detection of O-GlcNAc-modified proteins |
Q38796983 | What Have We Learned from Glycosyltransferase Knockouts in Mice? |
Q34620863 | X marks the spot: does it matter that O-GlcNAc transferase is an X-linked gene? |
Q33997535 | X-inactivation normalizes O-GlcNAc transferase levels and generates an O-GlcNAc-depleted Barr body |
Search more.